Appearance of oral Gaucher disease treatment, ‘Cerdelga’

Sanofi Genzyme has started to enter competition in the Gaucher disease treatment market as launching Cerdelga(generic name: eliglustat), an oral Gaucher disease treatment, with the health insurance benefits.

Sanofi Genzyme held a press conference to celebrate the launch of Cerdelga, an oral treatment for Gaucher disease type 1, and revealed it treatment status and clinical trial results on the...